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Abstract
Background: Behçet’s disease (BD) susceptibility had been associated with single-nucleotide polymorphisms (SNPs)
in IL23R–IL12RB2, IL10, STAT4, or ERAP1 locus in Japanese, Turkish, Chinese, and other populations, but not in a
Korean genome-wide association study (GWAS). We aimed to fine-map BD risk association of these four loci using
extensive imputation and additional genotyping for replication.
Methods: In the discovery phase, 369 patients with BD enrolled in the previous Korean GWAS and 2000 controls
retrieved from a population-based cohort of healthy Koreans were imputed for their genotypes of all SNPs in the
four loci using the Asian data of the 1000 Genomes Project as reference. For genotype imputation of ERAP1 SNPs,
the adjacent ERAP2 SNPs were also covered. For the 10 most significantly associated SNPs (8 imputed and 2 GWAS-
genotyped), an additional 84 patients with BD and 283 healthy controls were genotyped for replication. The results
from the discovery and replication phases were pooled for meta-analysis using the Mantel-Haenszel test to estimate
the odds ratio (OR) and 95% confidence interval (CI).
Results: An IL23R–IL12RB2 intergenic SNP rs1495965 was significantly associated with BD risk (OR (95% CI) = 1.5 (1.3,
1.7), P = 2.5 × 10−7) in the pooled meta-analysis of the discovery (1.4 (1.2, 1.7), P = 4.9 × 10−7) and replication (1.9 (1.3,
2.6), P = 6.0 × 10−4) phases. BD risk association was fine-mapped on the intergenic region rather than the two
flanking genes, as rs1495966 and rs4655535, almost perfectly correlated with rs1495965 (r2 = 0.99), were also located
in the same intergenic region. Consistent with previous reports, the P values tended to be lower within IL23R than
IL12RB2. On the other hand, several IL10 SNPs were suggested for association in the discovery phase but all failed in
the replication phase. No SNP in ERAP1–ERAP2 and STAT4 was suggested even in the discovery phase.
Conclusions: BD susceptibility association was fine-mapped on the intergenic region between IL23R and IL12RB2 as
marked by three correlated SNPs, rs1495965, rs1495966, and rs4655535.
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Background
Behçet’s disease (BD) is a chronic relapsing inflammatory
disease characterized by orogenital ulcers, cutaneous in-
flammation and uveitis. In addition to its typical muco-
cutaneous and ocular manifestations, BD is a multi-
system disease that also targets musculoskeletal, vascu-
lar, nervous, and gastrointestinal systems [1]. Although
the etiology of BD remains unclear, it is well-established
that BD is strongly associated with HLA-B*51.
Since two landmark genome-wide association studies
(GWAS) performed on Japanese and Turkish populations
[2, 3] identified HLA-A, IL10, and IL23R–IL12RB2 to be
novel BD susceptibility loci, the association of IL10 and
IL23R–IL12RB2 with BD has been replicated thereafter in
various ethnic groups including the Chinese Han, Iranian,
and Western Algerian populations [4–9]. The identification
of IL10 and IL23R–IL12RB2 not only indicates involvement
of non-HLA genes but also implies the importance of cyto-
kine dysregulation in the pathogenesis of BD.
Additional BD susceptibility loci other than IL10 and
IL23R–IL12RB2 identified by subsequent GWAS include
STAT4 in the Chinese Han [10] and GIMAP in Koreans
[11]. STAT4 is a transcription factor that transduces IL-
12, IL-23, and type 1 interferon signals in T cells and
monocytes [12]. Thus, the functional relevance of STAT4
in BD appears sensible because T helper (Th) 1 and Th17
cytokines are closely related to BD pathogenesis [13–15].
Notably, the Korean GWAS, which identified association
between BD and GIMAP, failed to replicate the association
with IL10, IL23R–IL12RB2, or STAT4 [11]. This lack of as-
sociation could have been due to insufficient statistical
power of the study (limitation in sample size or SNP dens-
ity) or due to the unique ethnic background.
The imputation technique, coupled with the GWAS
database, has been successfully used in studying BD gen-
etics to achieve genome-wide fine-mapping. By enhan-
cing SNP density and thereby helping identify the most
strongly associated among virtually all SNPs in a region
of interest, genotype imputation can upgrade the statis-
tical power of GWAS. Applying this technique in the
GWAS database has enabled identification of the associ-
ation with STAT4 in the Turkish and Japanese popula-
tions and recessive association with two nonsynonymous
ERAP1 SNPs in the Turkish population [16]. Their
minor alleles were too few in the Japanese population to
evaluate the recessive effect. ERAP1 homozygotes of the
BD risk-associated allele conferred the risk preferentially
to HLA-B*51 positive individuals, suggesting a gene-
gene interaction between ERAP1 and HLA-B*51.
We hypothesized that those susceptibility genes identi-
fied in other Asian groups are associated with BD in Ko-
reans as well and selected the genetic regions to be
imputed, where their association has been confirmed in
at least two Asian groups at GWAS level sample size.
ERAP1 was also selected to examine a gene-gene inter-
action with HLA-B*51 in our population. Finally, we
aimed to fine-map IL23R–IL12RB2, IL10, and STAT4 re-
gions and ERAP1 by applying imputation technique to
our Korean GWAS dataset.
Methods
Study participants
A total of 369 Korean patients with BD (cases) enrolled
in a previous GWAS [11] and 2000 age-matched and
sex-matched controls retrieved from a population-based
cohort of healthy Koreans (Korea Biobank Network,
http://cdc.co.kr) were included in this study. For replica-
tion, a different set of 84 Korean patients with BD and
283 age-matched and sex-matched healthy controls who
had not been included in the discovery phase were re-
cruited. Patients with BD fulfilled the International
Study Group diagnostic criteria for BD [17].
Genotype imputation in the discovery phase
Using the Asian dataset (CHB + JPT) of the 1000 Ge-
nomes Project as a reference panel, the missing geno-
types in the four loci were inferred for 369 cases and
2000 controls after phasing the observed genotypes de-
rived from the Korean GWAS data [11]. Before phasing,
the GWAS genotypes determined by the Affymetrix
genome-wide human SNP array 6.0 were screened for
quality control in terms of call rate (>95%), minor allele
frequency (>5%), and Hardy-Weinberg equilibrium P
value in controls (>0.0001). Boundaries of imputation
ranges were determined to include linkage disequilib-
rium (LD) blocks where the qualified GWAS SNPs of a
given gene reside.
For IL10, SNPs with minor allele frequency of 1–5%
were additionally included due to the paucity of GWAS
SNPs in this region if they satisfy the other quality con-
trol measures and if their signal clusters showed correct
call decisions in manual inspection. ERAP2 SNPs were
included for high-quality imputation of ERAP1 SNP ge-
notypes since the LD block expanded from ERAP1 to
ERAP2. The MATCH v1.0.16 software (University of
Michigan, Ann Arbor, MI, USA) was used to perform
the imputation. While 109 SNPs of the four loci had
been genotyped in the previous GWAS, 1629 additional
SNPs were imputed and passed a cutoff of imputation
quality, r square (Rsq) > 0.3 in this study.
Direct genotyping in the replication phase
Among the imputed SNPs, two IL10 SNPs with a lower P
value for BD risk association than the GWAS SNP
rs1554286 and six IL23R–IL12RB2 SNPs with a lower or
similar P value than the GWAS SNP rs6677188 were se-
lected together with the two GWAS SNPs for a replication
study. Thus, 10 lead SNPs (3 in IL10 and 7 in IL23R–
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IL12RB2) were genotyped in an additional population of 84
BD cases and 283 controls using the Taqman® primers and
probes designed by Applied Biosystems (Foster City, CA,
USA).
Statistical analysis for BD association
The chi-square test or Fisher’s exact test was used to com-
pare the allele frequencies between patient cases and
healthy controls. Statistical analysis was done using the
SPSS v17.0 software (SPSS Inc., Chicago, IL, USA). For
meta-analysis, data were pooled and analyzed according
to the Mantel-Haenszel test using the Stata v14 software
(StataCrop LP, College Station, TX, USA). Between-study
heterogeneity was quantified using the I2 statistic.
Results
Clinical characteristics of study participants
The clinical manifestations of patients with BD in the dis-
covery and replication phases are separately summarized in
Table 1. Compared to the GWAS population enrolled in the
discovery phase, the replication phase population had more
women (57% vs. 50%), more skin lesions (96.3% vs. 89.2%
for any skin lesion, P= 0.04; and 61.4% vs. 54.6% positivity
in pathergy testing), but fewer eye lesions (28.8% vs 43.5%,
P= 0.01). Central nervous system involvement was more
frequent in the discovery phase (11.6% vs. 3.8%, P= 0.03).
LD structure comparison in Asian populations
In order to see whether the 1000 Genomes Project data
can be used as reference for imputing the Korean geno-
types of the four loci, we first examined similarity of LD
structures of HapMap-scale SNPs in the loci between the
Korean genotype data of the Korean HapMap Project
(equivalent to the International HapMap Project) and the
Chinese and Japanese (referred to as Asian) sequence data
of the 1000 Genomes Project.
The correlation coefficient (r2) was calculated for all
SNPs within each of the four loci in reference to the
SNP that was most significant in the Korean GWAS
(rs6677188 in IL23R–IL12RB2, rs1554286 in IL10,
rs1031508 in STAT4, and rs26652 in ERAP1–ERAP2)
using the Korean genotype data and Asian sequence data
separately. Then, SNP distributions plotted in descend-
ing order of r2 values were compared between the two
populations (Additional file 1: Figure S1). The two plots
were nearly superimposable across all SNPs in each of
IL10, IL12RB–IL23R, and STAT4 loci and across the
highly correlated SNPs (0.5 ≤ r2 ≤ 1.0) in ERAP1–ERAP2.
Association analysis in the discovery phase
In the IL23R–IL12RB2 locus ranging from − 22.7 kb of
IL23R to + 54.3 kb of IL12RB2, 37 SNPs had been geno-
typed in the previous GWAS [11] and 509 additional
SNPs were imputed in this study for association tests
(Fig. 1). The most significantly associated SNP was
rs4655535 (imputed, OR = 1.4 (1.2, 1.7), P = 0.000033),
which had a sixfold lower P value than the GWAS-
genotyped SNP rs6677188 (P = 0.00020), which had the
same OR and 95% CI (Table 2).
Furthermore, four other SNPs (rs1495966, rs1495965,
rs6665569, and rs1966176 in ascending order of P value)
had lower P values (0.000038 ≤ P ≤ 0.00011) and rs924080
had a similar P value (P = 0.00022) compared to
rs6677188. These SNPs were all located within the inter-
genic region except for rs1966176 located within the
IL23R gene as shown in Fig. 1. Subsequently, seven SNPs
(rs4655535, rs1495966, rs1495965, rs6665569, rs1966176,
rs924080, and rs6677188) were chosen to be genotyped
for replication of BD risk association. As seen in Turkish
and Iranian studies [3, 8], many SNPs located within the
IL23R gene had lower P values than any SNP located
within the IL12RB2 gene, although it needs to be verified
Table 1 Clinical characteristics of the enrolled patients with Behçet’s disease
Characteristic Discovery phase (n = 379) Replication phase (n = 84) P valueb
Male (%): female 191 (50): 188 36 (43): 48
Age at diagnosis of BD (years)a 41.6 ± 10.1 44.1 ± 11.4
Clinical manifestation (%)
Recurrent oral ulcer 100 100
Recurrent genital ulcer 74.4 80.0
Skin lesions 89.2 96.3 0.04
Eye lesions 43.5 28.8 0.01
Positive pathergy test 54.6 (130/238) 61.4 (27/44)
Vascular involvement 16.4 17.5
Central nervous system involvement 11.6 3.8 0.03
Joint involvement 41.4 51.3
BD Behçet’s disease
aAge is presented as mean ± standard deviation
bOnly P values <0.05 are presented
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Fig. 1 Manhattan plot for the IL23R–IL12RB2 locus. All imputed (solid red circles) and genome-wide association study (GWAS)-genotyped (open
blue circles) SNPs are plotted together with a linkage disequilibrium structure below
Table 2 Allelic association of SNPs after imputation in the discovery phase
Locus SNP Risk allele (%) HWE
P
Rsqc Allelic association
BD cases (n = 738) Controls (n = 4000) OR (95% CI) P
IL23R–IL12RB2 rs4655535 (G > T)a 467 (63) 2201 (55) 0.00023 0.40 1.4 (1.2, 1.7) 0.000033
rs1495966 (T > C)a 467 (63) 2204 (55) 0.00042 0.40 1.4 (1.2, 1.7) 0.000038
rs1495965 (C > T)a 466 (63) 2203 (55) 0.00050 0.40 1.4 (1.2, 1.7) 0.000049
rs6665569 (T > C)a 465 (53) 2210 (55) 0.047 0.48 1.4 (1.2, 1.6) 0.000094
rs1966176 (G > A)a 506 (69) 2442 (61) 0.61 0.87 1.4 (1.2, 1.7) 0.00011
rs6677188 (T > A)a,b 588 (80) 2919 (73) 0.034 NA 1.4 (1.2, 1.8) 0.00020
rs924080 (T > C)a 590 (80) 2940 (73) 0.11 0.77 1.4 (1.2, 1.7) 0.00022
IL10 rs1518110 (A > C) 563 (76) 2728 (68) 0.47 0.91 1.5 (1.2, 1.8) 0.000012
rs1518111 (T > C)a 563 (76) 2728 (68) 0.47 0.91 1.5 (1.2, 1.8) 0.000012
rs1800871 (A > G) 563 (76) 2728 (68) 0.47 0.87 1.5 (1.2, 1.8) 0.000012
rs1800872 (T > G)a 563 (76) 2728 (68) 0.47 0.87 1.5 (1.2, 1.8) 0.000012
rs3024490 (A > C) 563 (76) 2728 (68) 0.47 0.85 1.5 (1.2, 1.8) 0.000012
rs1554286 (A > G)a,b 551 (76) 2720 (68) 0.47 NA 1.5 (1.2, 1.8) 0.000030
SNP single-nucleotide polymorphism, BD Behçet’s disease, HWE Hardy-Weinberg equilibrium, Rsq r square, OR odds ratio, CI confidence interval, NA not applicable
aThe ten SNPs were genotyped in the subsequent replication phase
bThe two SNPs had been genotyped in the previous genome-wide association study [11] and the genotypes of the others were imputed in this study
cRsq is an imputation quality metric estimated for each imputed SNP
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whether the BD risk-associated intergenic SNPs affect ex-
pression of IL23R, IL12RB2, or both in future studies.
In the IL10 locus ranging from − 8.4 kb to + 23.1 kb,
four SNPs had been genotyped [11] and 34 SNPs were
imputed (Fig. 2). The most significantly associated SNPs
were rs1518110, rs1518111, rs1800871, rs1800872, and
rs3024490 (all imputed, OR (95% CI) = 1.5 (1.2, 1.8), P =
0.000012), which were perfectly correlated (r2 = 1.0) with
each other (Table 2). These five SNPs had only a slightly
lower P value (0.000030) and the same OR (95% CI) (1.5
(1.2, 1.8)]), compared to the GWAS-genotyped
rs1554286 (Table 2). Among these six highly correlated
SNPs, genotyping of any one would be sufficient for the
replication study, but three SNPs, rs1518111, rs1800872,
and rs1554286, were genotyped in the replication phase
just for redundant assurance.
In the STAT4 locus ranging from − 4.7 kb to + 9.4 kb,
25 SNPs had been genotyped [11] and 239 SNPs were
imputed, but no SNPs were associated with BD risk in
this Korean population (Fig. 3). In the ERAP1–ERAP2
locus ranging from − 14.0 kb of ERAP1 to + 112.0 kb of
ERAP2, 43 SNPs had been genotyped [11] and 847 SNPs
were imputed but no SNPs were associated (Fig. 4).
Minor allele homozygotes of two ERAP1 SNPs,
rs17482078, and rs10050860, had been associated with
Turkish BD [16], but their minor allele frequencies were
similar between BD cases and controls (4.9% vs. 4.4% for
rs17482078; 4.9% vs. 4.5% for rs10050860, respectively)
without such homozygote carriers in this study.
Association analysis in the replication phase
The above-mentioned seven IL23R–IL12RB2 SNPs and
three IL10 SNPs were genotyped in a replication popula-
tion consisting of 89 BD cases and 283 healthy controls
of Korean ethnicity (Table 3). All SNPs in IL23R–
IL12RB2 maintained BD risk association with P values
(0.00062 ≤ P ≤0.0049) lower than the significance level
for multiple testing, α = 0.05/10 = 0.005 (for 10 SNPs),
except for rs6665569 (P = 0.0063). The OR values of
these seven SNPs were higher with experimentally deter-
mined genotype data in the replication phase (1.6 ≤OR
≤2.1) than with imputed genotype data in the discovery
phase (OR = 1.4), although their 95% CI overlapped.
However, the association between the three IL10 SNPs
and risk of BD was no longer significant in the replica-
tion phase, as the P values were much higher than a
Fig. 2 Manhattan plot for the IL10 locus. All imputed (solid red circles) and genome-wide association study (GWAS)-genotyped (open blue circles)
SNPs are plotted together with a linkage disequilibrium structure below
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Fig. 3 Manhattan plot for STAT4 locus. All imputed (solid red circles) and genome-wide association study (GWAS)-genotyped (open blue circles)
SNPs are plotted together with a linkage disequilibrium structure below
Fig. 4 Manhattan plot for the ERAP1–ERAP2 locus. All imputed (solid red circles) and genome-wide association study (GWAS)-genotyped (open
blue circles) SNPs are plotted together with a linkage disequilibrium structure below. The top panel represents the allelic association and the
bottom one represents the recessive association
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marginal significance level of α = 0.05 (Table 3). Associ-
ation test results were the same for the three highly cor-
related SNPs when they were re-genotyped for 20
randomly chosen cases of BD and 42 controls, with al-
ternatively designed primers and probes in a blinded
manner, rejecting any possibility of technical or sampling
errors in genotyping.
Meta-analysis
The discovery and replication phase data of the seven lead
SNPs in the IL23R–IL12RB2 locus were combined for
meta-analysis (Table 4). All seven SNPs were significantly
associated with BD susceptibility, as their P values passed a
significance level for multiple testing of all 1629 imputed
and 109 genotyped SNPs, α = 0.05/1738 = 2.9 × 10−5: the P
Table 3 Allelic association of SNPs in the replication phase





OR (95% CI) P
IL23R–IL12RB2 rs1495965 (C > T) 106/168 (63) 272/566 (48) 1.9 (1.3, 2.6) 0.00062
rs1495966 (T > C) 106/168 (63) 264/548 (48) 1.8 (1.3, 2.6) 0.00071
rs4655535 (G > T) 107/168 (64) 277/566 (49) 1.8 (1.3, 2.6) 0.00078
rs924080 (T > C) 143/168 (85) 413/566 (73) 2.1 (1.3, 3.4) 0.0013
rs1966176 (G > A) 118/168 (70) 322/562 (57) 1.8 (1.2, 2.6) 0.0026
rs6677188 (T > A) 142/168 (85) 419/566 (74) 1.9 (1.2, 3.0) 0.0049
rs6665569 (T > C) 103/168 (61) 271/550 (49) 1.6 (1.2, 2.3) 0.0063
IL10 rs1518111 (A > G) 120/168 (71) 408/566 (72) 1.0 (0.7, 1.4) 0.87
rs1800872 (A > C) 120/168 (71) 408/566 (72) 1.0 (0.7, 1.4) 0.87
rs1554286 (T > C) 120/168 (71) 396/554 (71) 1.0 (0.7, 1.5) 0.99
SNP single-nucleotide polymorphism, BD Behçet’s disease, OR odds ratio, CI confidence interval
Table 4 Meta-analysis on allelic associations of IL23R–IL12RB2 SNPs
SNP Phase BD cases, risk allele/total Controls, risk allele/total Weight % I2 % OR (95% CI) P
rs1495965 Dis. 467/738 (63) 2203/4000 (55) 83.7 35 1.41 (1.20, 1.65) 0.000049
Rep. 106/168 (63) 272/566 (48) 16.3 1.85 (1.30, 2.63) 0.00060
Total 573/906 (63) 2475/4566 (54) 1.47 (1.27, 1.70) 0.00000025
rs4655535 Dis. 467/738 (63) 2201/4000 (55) 83.7 27 1.41 (1.20, 1.66) 0.000033
Rep. 107/168 (64) 277/566 (49) 16.3 1.83 (1.28, 2.61) 0.00080
Total 574/906 (63) 2478/4566 (54) 1.47 (1.27, 1.71) 0.00000026
rs1495966 Dis. 467/738 (63) 2204/4000 (55) 83.4 0 1.40 (1.19, 1.64) 0.000038
Rep. 106/168 (63) 264/548 (48) 16.6 1.84 (1.29, 2.62) 0.00070
Total 573/906 (63) 2464/4548 (54) 1.47 (1.27, 1.70) 0.00000029
rs1966176 Dis. 506/738 (69) 2443/4000(61) 83.6 5 1.39 (1.18, 1.64) 0.00011
Rep. 118/168 (70) 322/562 (57) 16.4 1.76 (1.21, 2.55) 0.0026
Total 624/906 (69) 2765/4562 (61) 1.45 (1.24, 1.69) 0.0000021
rs6665569 Dis. 465/738 (53) 2210/4000 (55) 83.0 0 1.38 (1.17, 1.62) 0.000094
Rep. 103/168 (61) 271/550 (49) 17.0 1.63 (1.15, 2.32) 0.0063
Total 568/906 (63) 2481/4550 (55) 1.42 (1.23, 1.65) 0.0000030
rs924080 Dis. 590/738 (80) 2940/4000 (74) 86.4 62 1.44 (1.18, 1.74) 0.00022
Rep. 143/168 (85) 413/566 (73) 13.6 2.12 (1.33, 3.37) 0.0013
Total 733/906 (81) 3353/4566 (73) 1.53 (1.28, 1.83) 0.0000032
rs6677188 Dis. 590/738 (80) 2937/4000 (73) 85.8 34 1.44 (1.19, 1.75) 0.00019
Rep. 142/168 (85) 419/566 (74) 14.2 1.92 (1.21, 3.03) 0.0049
Total 732/906 (81) 3356/4566 (73) 1.51 (1.26, 1.80) 0.0000060
SNP single-nucleotide polymorphism, BD Behçet’s disease, CI confidence interval, Dis. discovery phase, OR odds ratio, Rep. replication phase
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value was an order of magnitude lower for three SNPs,
rs1495965 (P = 2.5 × 10−7), rs4655535 (P = 2.6 × 10−7), and
rs1495966 (P = 2.9 × 10−7), than the other four SNPs (P ≥
2.1 × 10−6). The three lowest P value SNPs were almost per-
fectly correlated with each other (r2 = 0.99) and all located
in the intergenic region between IL23R and IL12RB2.
Discussion
This study investigated the previously BD-associated IL23R–
IL12RB2, IL10, STAT4, and ERAP1 loci for fine-mapping by
using comprehensive imputation for discovering candidate
SNPs and genotyping them in additional cases and controls
for independent replication of the association in Koreans.
Among the four loci, only IL23R–IL12RB2 was confirmed
for association with BD susceptibility in the pooled meta-
analysis of the discovery and replication phases, consistent
with several previous studies [2–4, 7].
More importantly, association between BD risk and the
IL23R–IL12RB2 locus was fine-mapped on the intergenic
region rather than the IL23R or IL12RB2 gene, as the most
significant association (P= 10−7) was observed with three al-
most perfectly correlated SNPs (r2 = 0.99), rs1495965,
rs1495966, and rs4655535 located in the intergenic region,
which may contain regulatory sequences for expression of
IL23R, IL12RB2, or both. These three SNPs were in
complete LD (D’= 1.0) with another intergenic SNP,
rs924080, which has been associated with IL23R expression.
More specifically, the risk-associated allele A of rs924080
was associated with enhanced expression of IL23R, IL6, and
TNFα in the previous Turkish study [18], although not in
the previous Chinese study [6], where IL23R and IL17
mRNA levels were affected by rs12141431 instead. It is
plausible to hypothesize that genetic polymorphisms in the
IL23R–IL12RB2 locus are associated with upregulated Th17
axis in BD. The importance of Th17 cells and cytokines in
BD has been shown in many studies. Elevated levels of
circulating Th17 cells or Th17 cytokines in BD have been
reported [13, 14, 19, 20] and successful anti-TNFα treatment
was found to decrease Th17 differentiation [15]. However,
the mechanism by which the BD-associated SNPs alter
disease susceptibility remains to be clarified.
Several IL10 SNPs were positive for association with BD in
the discovery phase but all failed in the replication phase. As-
sociation between BD and IL10 was previously evident with
rs1518111 in the Turkish GWAS [3] but was evident with
rs1800871 and rs1800872 in the Japanese GWAS [2],
whereas nominal association was observed with rs1518111
and rs1554286 in an Iranian population [7], which was not
replicated in another Iranian population [8], indicating con-
trasting results in different studies. In this study in Koreans,
the association test results were drastically different between
the discovery and replication phases. This discrepancy could
have been caused by heterogeneity of the enrolled subjects,
among other causes. For example, the discovery phase
population had significantly more eye and central nervous
system lesions and fewer skin lesions than the replication
phase population. It might be that the IL10 polymorphism is
preferentially involved in eye or central nervous system le-
sions, since the prevalence of the IL10 polymorphism in pa-
tients with BD was higher in the discovery phase (76%) than
in the replication phase (71%) whereas its prevalence was
similar in controls in both phases (68% in the discovery
phase vs. 71–72% in the replication phase). Another possible
cause could be that the sample size was too small in the rep-
lication phase, i.e. the statistical power was insufficient. A
more homogenous, larger sample will help further determine
the significance of IL10 polymorphisms in Koreans with BD.
We found no association with STAT4 and ERAP1–
ERAP2 loci. Alteration of STAT4 signaling or antigen
presentation of pathogenic peptides by SNPs [16] may
not be a major disease susceptibility mechanism in Ko-
reans. However, there is a possibility that the rare risk al-
leles may have been undetected by this fine mapping
due to limited statistical power.
Conclusion
Association was confirmed between susceptibility to BD and
the IL23R–IL12RB2 locus, and was fine-mapped on the inter-
genic region rather than the two flanking genes, suggesting
association with altered expression of IL23R, IL12RB2, or
both. The other three loci, IL10, STAT4, and ERAP1–ERAP2,
were not confirmed in this study with Koreans.
Additional file
Additional file 1 Figure S1. LD structure similarities of the four loci
(IL10, IL23R–IL12RB2, STAT4, or ERAP1) between Korean and Asian (Chinese
and Japanese) populations. Using the Korean and Asian genotype
databases, the correlation coefficient value (r2) was calculated for all the
SNPs within each of the four loci in reference to the SNP found to be
most significant in the Korean GWAS (rs1554286 in IL10, rs6677188 in
IL23R–IL12RB2, rs1031508 in STAT4, and rs26652 in ERAP1-ERAP2). The Y
axis shows r2 between the reference SNP and the other SNPs within each
gene. The X axis shows SNPs ranked in the descending order of r2 values.
In each plot, open circles represent SNPs from the Korean genotype
database and solid squares those from the Asian database. (TIF 65 kb)
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